Ovid Therapeutics Inc.
OVID· Nasdaq
Ovid Therapeutics Inc.
- Last sale
- Oct 2, 2026 · -1.45%
- Market cap
- $465.79M
- 195.3M shares
- Filings
- 532
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $7,252,000 | reported | |
| FY 2024 | 2024-12-31 | $566,000 | reported | |
| FY 2023 | 2023-12-31 | $392,000 | reported | |
| FY 2022 | 2022-12-31 | $1,502,748 | reported | |
| FY 2021 | 2021-12-31 | $208,382,779 | reported | |
| FY 2020 | 2020-12-31 | $12,617,221 | reported |
Ovid Therapeutics Inc. · CIK 1636651 · Engraved from SEC EDGAR
